Items where authors include "Brown, L.C."

Article

Sun, G., Fuller, H., Fenton, H. et al. (7 more authors) (2025) The relationship between dietary and supplemental n-3 HUFA intake, blood and tissue n-3 HUFA levels, and colorectal polyp recurrence: A secondary analysis of the seAFOod polyp prevention trial. The Journal of Nutrition, 155 (2). pp. 549-558. ISSN 0022-3166

Sun, G., Fuller, H., Fenton, H. et al. (7 more authors) (2024) The effect of aspirin and eicosapentaenoic acid on urinary biomarkers of prostaglandin E2 synthesis and platelet activation in participants of the seAFOod polyp prevention trial. International Journal of Cancer, 154 (5). pp. 873-885. ISSN 0020-7136

Sun, G., Fuller, H., Fenton, H. et al. (7 more authors) (2024) The effect of aspirin and eicosapentaenoic acid on urinary biomarkers of prostaglandin E2 synthesis and platelet activation in participants of the seAFOod polyp prevention trial. International Journal of Cancer, 154 (5). pp. 873-885. ISSN 0020-7136

Buckle, R.L., Brown, L.C. and Aziz, I. orcid.org/0000-0003-4313-0553 (2024) Randomized trial in postprandial functional dyspepsia: reassurance and diagnostic explanation with or without traditional dietary advice. Neurogastroenterology & Motility, 36 (3). e14733. ISSN 1350-1925

Davies, J.R. orcid.org/0009-0002-4272-2477, Mell, T. orcid.org/0009-0001-6744-1340, Fuller, H. orcid.org/0000-0001-8381-519X et al. (10 more authors) (2023) Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial. Cancer Prevention Research, 16 (11). pp. 621-630. ISSN 1940-6207

Davies, J.R. orcid.org/0009-0002-4272-2477, Mell, T. orcid.org/0009-0001-6744-1340, Fuller, H. orcid.org/0000-0001-8381-519X et al. (10 more authors) (2023) Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial. Cancer Prevention Research, 16 (11). pp. 621-630. ISSN 1940-6207

Downing, A., Fenton, H., Nickerson, C. et al. (6 more authors) (2023) Colorectal polyp outcomes after participation in the seAFOod polyp prevention trial: evidence of rebound elevated colorectal polyp risk after short-term aspirin use. Alimentary Pharmacology & Therapeutics, 58 (6). pp. 562-572. ISSN 1365-2036

Downing, A. orcid.org/0000-0002-0335-7801, Fenton, H., Nickerson, C. et al. (6 more authors) (2023) Colorectal polyp outcomes after participation in the seAFOod polyp prevention trial: Evidence of rebound elevated colorectal polyp risk after short-term aspirin use. Alimentary Pharmacology and Therapeutics, 58 (6). pp. 562-572. ISSN 0269-2813

Fuller, H., Race, A.D., Fenton, H. et al. (7 more authors) (2023) Plasma and rectal mucosal oxylipin levels during aspirin and eicosapentaenoic acid treatment in the seAFOod polyp prevention trial. Prostaglandins, Leukotrienes and Essential Fatty Acids, 192. 102570. ISSN 0952-3278

Fuller, H., Race, A.D., Fenton, H. et al. (7 more authors) (2023) Plasma and rectal mucosal oxylipin levels during aspirin and eicosapentaenoic acid treatment in the seAFOod polyp prevention trial. Prostaglandins, Leukotrienes and Essential Fatty Acids, 192. 102570. ISSN 0952-3278

Blagden, S.P., Billingham, L., Brown, L.C. et al. (13 more authors) (2020) Effective delivery of Complex Innovative Design (CID) cancer trials—A consensus statement. British Journal of Cancer, 122 (4). pp. 473-482. ISSN 0007-0920

Greenhalgh, R.M., Brown, L.C., Epstein, D. et al. (4 more authors) (2005) Endovascular aneurysm repair and outcome in patients unfit for open repair of abdominal aortic aneurysm (EVAR trial 2): randomised controlled trial. The Lancet, 365 (9478). pp. 2187-2192. ISSN 0140-6736

Greenhalgh, R.M., Brown, L.C., Epstein, D. et al. (4 more authors) (2005) Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial. The Lancet, 365 (9478). pp. 2179-2186. ISSN 0140-6736